Skip to main content

Artemis Funds (Lux) – US Extended Alpha fund review of the year to 30 April 2023

Adrian Brass, James Dudgeon and William Warren, managers of the Artemis Funds (Lux) – US Extended Alpha, report on the fund over the year to 30 April 2023

Main changes to the fund

  • Early in the period we started to add to ‘early cyclical’ areas where we thought recession was already priced in. Examples included Burlington Stores (off price retail), Restoration Hardware (home furnishings), Azek (composite decking) and Ferguson (distributor). Later we added Topbuild (insulation).
  • We made some changes to our healthcare positioning, selling out of Zoetis and Pfizer where we struggle to make the case for an attractive risk/reward and instead initiating a position in Avantor. Avantor is a leading life sciences distribution business with highly recurring revenues and a good growth outlook backed by a large exposure to biopharma.
  • Short ideas included companies that we think are still significantly over earning compared to pre 2020 but also a number of industrial and consumer cyclicals where the share prices were not reflecting the reality of falling activity levels.

Explaining the fund’s performance

  • The fund returned 6.7%, behind the S&P 500’s return of 8.6%1. Among the biggest detractors from performance were:
  • First Republic: When Silicon Valley Bank started to experience problems, the market focused on other banks with uninsured deposits. We sold First Republic, but the share price had already suffered. Our other holding in the banking sector, Wells Fargo, also saw its share price weaken.
  • Nvidia: Nvidia underweight dampened returns in 2023 as the market rotated out of banks and into technology shares. We established a position in Nvidia to correct this.
  • Constellation Energy: Underperformed due to profit-taking after the stock performed very well last year. We remain very optimistic about the long-term prospects for Constellation, as it should benefit from the Inflation Reduction Act (IRA).

The wider context

  • The failure of Silicon Valley Bank at the start of March led to fears of contagion to the rest of the banking sector and a deposit run on other smaller banks. The situation with the banks led to a marked rotation in the market out of financials and into technology shares.

Looking ahead

  • The economic backdrop is one of increased risk and uncertainty, but one we believe offers substantial opportunity. We have positioned the fund for the economic slowdown to continue working its way through the economy from early to late cycle sectors. This positioning has started to pay off but we believe there is further to go. The majority of the fund on the long side is invested in discounted compounders. These are secular growth companies with relatively low economic sensitivity. The overall positioning of the fund is moderately defensive with an overall net exposure of 97%.
Discrete performance, 12 months to 31 December 2022 2021 2020 2019 2018
 Artemis Funds (Lux) – US Extended Alpha -18.9% 22.8% 19.7% 28.5% N/A
S&P 500 TR -18.1% 28.7% 18.4% 31.5% N/A
1 Artemis/Lipper Limited, class I accumulation USD. 
*Past performance is not a guide to the future.
Source: Artemis/Lipper Limited, class I accumulation USD. All figures show total returns with dividends and/or income reinvested, net of all charges. Performance does not take account of any costs incurred when investors buy or sell the fund. Returns may vary as a result of currency fluctuations if the investor's currency is different to that of the class.

Investment in a fund concerns the acquisition of units/shares in the fund and not in the underlying assets of the fund.

Reference to specific shares or companies should not be taken as advice or a recommendation to invest in them.

For information on sustainability-related aspects of a fund, visit the relevant fund page on this website.

For information about Artemis’ fund structures and registration status, visit artemisfunds.com/fund-structures

Any research and analysis in this communication has been obtained by Artemis for its own use. Although this communication is based on sources of information that Artemis believes to be reliable, no guarantee is given as to its accuracy or completeness.

Any statements are based on Artemis’ current opinions and are subject to change without notice. They are not intended to provide investment advice and should not be construed as a recommendation.

Third parties (including FTSE and Morningstar) whose data may be included in this document do not accept any liability for errors or omissions. For information, visit artemisfunds.com/third-party-data.

Important information
The intention of Artemis’ ‘investment insights’ articles is to present objective news, information, data and guidance on finance topics drawn from a diverse collection of sources. Content is not intended to provide tax, legal, insurance or investment advice and should not be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security or investment by Artemis or any third-party. Potential investors should consider the need for independent financial advice. Any research or analysis has been procured by Artemis for its own use and may be acted on in that connection. The contents of articles are based on sources of information believed to be reliable; however, save to the extent required by applicable law or regulations, no guarantee, warranty or representation is given as to its accuracy or completeness. Any forward-looking statements are based on Artemis’ current opinions, expectations and projections. Articles are provided to you only incidentally, and any opinions expressed are subject to change without notice. The source for all data is Artemis, unless stated otherwise. The value of an investment, and any income from it, can fall as well as rise as a result of market and currency fluctuations and you may not get back the amount originally invested.